Daiichi Sankyo Co. Ltd. (TYO:4568) is making antibody drug conjugates (ADCs) and other next-generation biopharmaceuticals a pillar for medium- and…...
Please subscribe to read the full story.
Daiichi Sankyo
Daiichi Sankyo Partners With US Firm to Enter Cancer Cell Therapy Market
Daiichi Sankyo Co. Ltd. (TYO:4568) is entering Japan’s market for anti-cancer cell therapy drugs in partnership with U.S.-based Kite Pharma…...
Please subscribe to read the full story.
Industry Outlook 2017: Pharmaceuticals Part 3 – Regenerative Medicine
Active efforts are under way to research and commercialize products with applications for regenerative medicine, a field that is expected…...
Please subscribe to read the full story.
